365) oglia, and inflammatory microglia and the molecular profiles that are associated wit |
366) that cause their distinct functional and molecular profiles. |
367) determined virulence-associated genes and molecular subtype changes of the surviving |
368) mimicked that found in basal/claudin-low molecular subtype within the triple negati |
369) However, recent progress in CRC molecular therapies may provide new insigh |
370) inical development of small molecules and molecular therapies. |
371) cribes facets of this phenomenon, but its molecular underpinnings are incompletely c |
372) and transcriptomic studies argue that the molecular underpinnings of the disease are |
373) effect of various polymer concentrations, molecular weights (Mws) and drug loads on |
374) luorescent dextran molecules of different molecular weights in biomaterials by fluor |
375) cters and 8 indices in 111 specimens) and molecular (sequences from the barcode regi |
376) This review chronicles the development of molecular CRC therapies over the past few |
377) nds was further studied through Classical Molecular Dynamic Simulations and the conf |
378) Both Comparative Molecular Field Analysis (r(2) = .944 |
379) nd highlights recent advances in defining molecular aberrations that may ultimately |
380) fficulties in conformational flexibility, molecular alignment, pharmacophore feature |
381) insularum using a molecular approach, the partial sequences |
382) h Cebus/Saimiri), were clarified with new molecular approaches based on the presence |
383) ight and scanning electron microscopy and molecular approaches, a new species of Asp |
384) Molecular assay based on 16S rDNA is helpf |
385) The strong survival capacity and molecular attributes of V. |
386) uencing will hopefully bring to light new molecular bases of syndromes with poikilod |
387) factors are involved in the regulation of molecular bi-directional pathways during f |
388) Recent advances in the field of molecular biology, "omics" technology and |
389) Thus, we investigated a molecular biomarker to determine the sensi |
390) ion of well characterised study bases for molecular cancer research will be an essen |
391) of the intervertebral disc to the latest molecular, cell-based therapies and tissue |
392) The HSP90 molecular chaperone plays a key role in th |
393) expression increase in spliced XBP-1 and molecular chaperons, accompanied by signif |
394) le method to coat microneedles with small molecular chemical drugs or large proteins |
395) er its interacting mechanical pathway and molecular circuitry. |
396) tep toward the construction of artificial molecular circuits for dynamic control of |
397) which subsequently recruited an autophagy molecular complex containing Beclin1 and B |
add keyword